,"Author: Lane, David Anthony",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 32 (Of the 116 documents considered for the h-Index, 32 have been cited at least 32 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,7813,757,739,1496,496,9805
2009,"Essential role of the disintegrin-like domain in ADAMTS13 function.","de Groot R., Bardhan A., Ramroop N., Lane D.A., Crawley J.T.",15280020,"Blood",113, 22,0,0,0,0,0,0
2009,"Global capitalism and the transformation of state socialism","Lane D.",00393606,"Studies in Comparative International Development",44, 2,0,0,0,0,0,0
2009,"Afunctional calcium-binding site in the metalloprotease domain ofADAMTS13","Chion C.K.N.K., Groot R.D., Shah A., Crawley J.T.B., Lane D.A.",00064971,"Blood",113, 5,0,0,0,0,0,0
2009,"Molecular basis of the supercoil deficit induced by the mini-F plasmid partition complex","Bouet J.-Y., Lane D.",00219258,"Journal of Biological Chemistry",284, 1,0,0,0,0,0,0
2008,"Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF?B activity: Implications for cancer therapy","Dey A., Wong E., Kua N., Hsiang L.T., Tergaonkar V., Lane D.",15384101,"Cell Cycle",7, 23,0,0,0,0,1,1
2008,"F plasmid partition depends on interaction of SopA with non-specific DNA","Castaing J.-P., Bouet J.-Y., Lane D.",0950382X,"Molecular Microbiology",70, 4,0,0,0,0,1,1
2008,"Shear tango: Dance of the ADAMTS13/VWF complex","De Groot R., Lane D.A.",00064971,"Blood",112, 5,0,0,0,0,0,0
2008,"From Chaotic to state-led capitalism","Lane D.",13563467,"New Political Economy",13, 2,0,0,0,0,0,0
2008,"Extended function of plasmid partition genes: The sop system of linear phage-plasmid N15 facilitates late gene expression","Ravin N.V., Rech J., Lane D.",00219193,"Journal of Bacteriology",190, 10,0,0,0,0,0,0
2008,"Evidence that high von Willebrand factor and low ADAMTS-13 levels independently increase the risk of a non-fatal heart attack","Crawley J.T.B., Lane D.A., Woodward M., Rumley A., Lowe G.D.O.",15387933,"Journal of Thrombosis and Haemostasis",6, 4,0,0,0,0,2,2
2008,"N-linked glycosylation of VWF modulates its interaction with ADAMTS13","McKinnon T.A.J., Chion A.C.K., Millington A.J., Lane D.A., Laffan M.A.",00064971,"Blood",111, 6,0,0,0,0,2,2
2008,"Double-blind review: Easy to guess in specialist fields","Lane D.",00280836,"Nature",452, 7183,0,0,1,1,0,1
2008,"The haemostatic role of tissue factor pathway inhibitor","Crawley J.T.B., Lane D.A.",10795642,"Arteriosclerosis, Thrombosis, and Vascular Biology",28, 2,0,0,5,5,12,17
2008,"Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura","Camilleri R.S., Cohen H., Mackie I.J., Scully M., Starke R.D., Crawley J.T.B., Lane D.A., Machin S.J.",15387933,"Journal of Thrombosis and Haemostasis",6, 2,0,0,1,1,5,6
2008,"Building on strength","Greaves M., Lane D.A.",15387933,"Journal of Thrombosis and Haemostasis",6, 1,0,0,0,0,0,0
2007,"Post-communist states and the European Union","Lane D.",13523279,"Journal of Communist Studies and Transition Politics",23, 4,0,0,0,0,0,0
2007,"Plasmid partition and incompatibility - The focus shifts","Bouet J.-Y., Nordstrom K., Lane D.",0950382X,"Molecular Microbiology",65, 6,0,1,3,4,3,7
2007,"The central role of thrombin in hemostasis","Crawley J.T.B., Zanardelli S., Chion C.K.N.K., Lane D.A.",15387933,"Journal of Thrombosis and Haemostasis",5, 1,0,1,7,8,9,17
2007,"Association of protein S p.Pro667Pro dimorphism with plasma protein S levels in normal individuals and patients with inherited protein S deficiency","Castaman G., Faioni E.M., Biguzzi E., Razzari C., Tosetto A., Fontana G., Asti D., Brancaccio V., Castori D., Lane D.A.",00493848,"Thrombosis Research",120, 3,0,0,1,1,0,1
2007,"Further characterization of ADAMTS-13 inactivation by thrombin","Lam J.K., Chion C.K.N.K., Zanardelli S., Lane D.A., Crawley J.T.B.",15387933,"Journal of Thrombosis and Haemostasis",5, 5,0,1,1,2,4,6
2007,"Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3","Villegas-Mendez A., Montes R., Ambrose L.R., Warrens A.N., Laffan M., Lane D.A.",15387933,"Journal of Thrombosis and Haemostasis",5, 5,0,0,3,3,1,4
2007,"ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men","Chion C.K.N.K., Doggen C.J.M., Crawley J.T.B., Lane D.A., Rosendaal F.R.",00064971,"Blood",109, 5,0,4,7,11,3,14
2007,"Testimony and new challenges","Greaves M., Lane D.A.",15387933,"Journal of Thrombosis and Haemostasis",5, 3,0,1,0,1,0,1
2007,"Polymerization of SopA partition ATPase: Regulation by DNA binding and SopB","Bouet J.-Y., Ah-Seng Y., Benmeradi N., Lane D.",0950382X,"Molecular Microbiology",63, 2,0,8,7,15,4,19
2006,"Concerted action of plasmid maintenance functions: Partition complexes create a requirement for dimer resolution","Bouet J.-Y., Bouvier M., Lane D.",0950382X,"Molecular Microbiology",62, 5,0,2,2,4,1,5
2006,"Multifunctional specificity of the protein C/activated protein C Gla domain","Preston R.J.S., Ajzner E., Razzari C., Karageorgi S., Dua S., Dahlback B., Lane D.A.",00219258,"Journal of Biological Chemistry",281, 39,0,7,10,17,5,22
2006,"Binding of calcium to anticoagulant protein S: Role of the fourth EGF module","Persson K.E.M., Stenflo J., Linse S., Stenberg Y., Preston R.J.S., Lane D.A., Rezende S.M.",00062960,"Biochemistry",45, 35,0,3,1,4,1,5
2006,"Role of a 5?-enhancer in the transcriptional regulation of the human endothelial cell protein C receptor gene","Mollica L.R., Crawley J.T.B., Liu K., Rance J.B., Cockerill P.N., Follows G.A., Landry J.-R., Wells D.J., Lane D.A.",00064971,"Blood",108, 4,0,6,3,9,1,10
2006,"Erratum: ParABS systems of the four replicons of Burkholderia cenocepacia: New chromosome centromeres confer partition specificity (Journal of Bacteriology (2006) 188, 4 (1489-1496))","Dubarry N., Pasta F., Lane D.",00219193,"Journal of Bacteriology",188, 8,0,0,0,0,0,0
2006,"Autoantibodies to thrombin directed against both of its cryptic exosites","Mollica L., Preston R.J.S., Chion A.C.K., Lees S.J., Collins P., Lewis S., Lane D.A.",00071048,"British Journal of Haematology",132, 4,0,2,1,3,0,3
2006,"ParABS systems of the four replicons of Burkholderia cenocepacia: New chromosome centromeres confer partition specificity","Dubarry N., Pasta F., Lane D.",00219193,"Journal of Bacteriology",188, 4,2,5,6,11,1,14
2006,"ADAMTS13 substrate recognition of von Willebrand factor A2 domain","Zanardelli S., Crawley J.T.B., Chan Kwo Chion C.K.N., Lam J.K., Preston R.J.S., Lane D.A.",00219258,"Journal of Biological Chemistry",281, 3,4,6,6,12,3,19
2005,"Directing thrombin","Lane D.A., Philippou H., Huntington J.A.",00064971,"Blood",106, 8,14,18,18,36,12,62
2005,"Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis","O'Donnell J.S., McKinnon T.A.J., Crawley J.T.B., Lane D.A., Laffan M.A.",00064971,"Blood",106, 6,2,7,5,12,3,17
2005,"Efficient isolation of peptide ligands for the endothelial cell protein C receptor (EPCR) using candidate receptor phage display biopanning","White S.J., Simmonds R.E., Lane D.A., Baker A.H.",01969781,"Peptides",26, 7,0,1,0,1,0,1
2005,"Molecular diversity and thrombotic risk in protein S deficiency: The PROSIT study","Biguzzi E., Simmonds R.E., Rezende S.M., Preston R., Prisco D., Faioni E.M., Finazzi G., Legnani C., Iannaccaro F., Rogolino A., Mori M., Razzari C., Armani U., Rossi E., Brancaccio V., Papa M.L., De Caterina M., Castori L., Berrettini M., De Stefano V., Faillace F., Barillari G., Lane D.A., Lippi G., Castaman G., Cappellari A., Bucciarelli P., Fontana G., Margaglione M., D'Andrea G.",10597794,"Human Mutation",25, 3,3,4,8,12,2,17
2005,"Proteolytic inactivation of ADAMTS13 by thrombin and plasmin","Crawley J.T.B., Lam J.K., Rance J.B., Mollica L.R., O'Donnell J.S., Lane D.A.",00064971,"Blood",105, 3,21,18,10,28,11,60
2005,"Probing plasmid partition with centromere-based incompatibility","Bouet J.-Y., Rech J., Egloff S., Biek D.P., Lane D.",0950382X,"Molecular Microbiology",55, 2,5,2,1,3,1,9
2005,"Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation","Preston R.J.S., Villegas-Mendez A., Sun Y.-H., Hermida J., Simioni P., Philippou H., Dahlback B., Lane D.A.",1742464X,"FEBS Journal",272, 1,9,3,2,5,2,16
2004,"Structural organization and control of expression of the sop operon of linear plasmid prophage N15","Ravin N.V., Dorokhov B.D., Lane D.",00268984,"Molekulyarnaya Biologiya",38, 2,0,0,0,0,0,0
2004,"Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death","Hurtado V., Hermida J., Montes R., Gris J.-C., Bertolaccini M.L., Alonso A., Martinez-Gonzalez M.A., Khamashta M.A., Fukudome K., Lane D.A.",00064971,"Blood",104, 5,20,7,4,11,3,34
2004,"Curing cancer with p53","Lane D.",00284793,"New England Journal of Medicine",350, 26,10,1,2,3,1,14
2004,"Protective Role for H-NS Protein in IS1 Transposition","Rouquette C., Serre M.-C., Lane D.",00219193,"Journal of Bacteriology",186, 7,7,3,1,4,1,12
2004,"Structural organization and control of expression of the sop operon of linear plasmid prophage N15","Ravin N.V., Dorokhov B.D., Lane D.",00268933,"Molecular Biology",38, 2,0,0,0,0,0,0
2004,"Coagulation, inflammation, and apoptosis: Different roles for protein S and the protein S-C4b binding protein complex","Rezende S.M., Simmonds R.E., Lane D.A.",00064971,"Blood",103, 4,28,9,15,24,5,57
2004,"Genetic studies in complex disease","Rosendaal F.R., Reitsma P.H., Mollica L., Lane D.A., Margaglione M., Merlini P., Ardissino D.",15387933,"Journal of Thrombosis and Haemostasis",2, 2,1,2,0,2,0,3
2004,"Kinetics of plasmid segregation in Escherichia coli","Gordon S., Rech J., Lane D., Wright A.",0950382X,"Molecular Microbiology",51, 2,22,5,5,10,1,33
2003,"Partition operon expression in the linear plasmid prophage N15 is controlled by both Sop proteins and protelomerase","Dorokhov B.D., Lane D., Ravin N.V.",0950382X,"Molecular Microbiology",50, 2,3,0,0,0,0,3
2003,"Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation","Philippou H., Rance J., Myles T., Hall S.W., Ariens R.A., Grant P.J., Leung L., Lane D.A.",00219258,"Journal of Biological Chemistry",278, 34,10,2,3,5,0,15
2003,"Mapping of functional domains in F plasmid partition proteins reveals a bipartite SopB-recognition domain in SopA","Ravin N.V., Rech J., Lane D.",00222836,"Journal of Molecular Biology",329, 5,15,2,2,4,1,20
2003,"Regulation of the human endothelial cell protein C receptor gene promoter by multiple Sp1 binding sites","Rance J.B., Follows G.A., Cockerill P.N., Bonifer C., Lane D.A., Simmonds R.E.",00064971,"Blood",101, 11,8,1,0,1,0,9
2003,"Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis","Raja S.M., Chhablani N., Swanson R., Thompson E., Laffan M., Lane D.A., Olson S.T.",00219258,"Journal of Biological Chemistry",278, 16,3,0,1,1,0,4
2003,"p53: 25 years of research and more questions to answer","Bourdon J.C., De Laurenzi V., Melino G., Lane D.",13509047,"Cell Death and Differentiation",10, 4,11,1,4,5,4,20
2003,"Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity","Mille-Baker B., Rezende S.M., Simmonds R.E., Mason P.J., Lane D.A., Laffan M.A.",00064971,"Blood",101, 4,10,0,2,2,1,13
2002,"Haemostatic gene polymorphisms in venous and arterial thrombosis","Lane D.A., Mollica L.R.",14248832,"Pathophysiology of Haemostasis and Thrombosis",32, 5-6,4,1,0,1,1,6
2002,"Protein S GLA-domain mutations causing impaired Ca2+-induced phospholipid binding and severe functional protein S deficiency","Rezende S.M., Lane D.A., Mille-Baker B., Samama M.M., Conard J., Simmonds R.E.",00064971,"Blood",100, 8,12,2,1,3,1,16
2002,"Naturally occurring mutations in the thrombomodulin gene leading to impaired expression and function","Kunz G., Ohlin A.-K., Adami A., Zoller B., Svensson P., Lane D.A.",00064971,"Blood",99, 10,13,2,2,4,1,18
2002,"The parAB gene products of Pseudomonas putida exhibit partition activity in both P. putida and Escherichia coli","Godfrin-Estevenon A.-M., Pasta F., Lane D.",0950382X,"Molecular Microbiology",43, 1,26,7,4,11,2,39
2002,"Genetic and phenotypic variability between families with hereditary protein S deficiency","Rezende S.M., Lane D.A., Zoller B., Mille-Baker B., Laffan M., Dahlback B., Simmonds R.E.",03406245,"Thrombosis and Haemostasis",87, 2,18,2,1,3,0,21
2001,"Role of the ATP-binding site of SopA protein in partition of the F plasmid","Libante V., Thion L., Lane D.",00222836,"Journal of Molecular Biology",314, 3,15,3,1,4,1,20
2001,"How cells choose to die","Lane D.",00280836,"Nature",414, 6859,15,2,0,2,0,17
2001,"Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism","Kuhle S., Lane D.A., Jochmanns K., Male C., Quehenberger P., Lechner K., Pabinger I.",03406245,"Thrombosis and Haemostasis",86, 4,13,3,6,9,0,22
2001,"The endothelial cell protein C receptor: A candidate genetic risk factor for thrombosis","Simmonds R.E., Lane D.A.",03406245,"Thrombosis and Haemostasis",86, 4,3,0,1,1,0,4
2000,"Disruption of the F plasmid partition complex in vivo by partition protein SopA","Lemonnier M., Bouet J.-Y., Libante V., Lane D.",0950382X,"Molecular Microbiology",38, 3,20,5,3,8,2,30
2000,"The A-Val34Leu polymorphism accelerates activation of FXIII by thrombin and affects fibrin structure","Ras A., Philippou H., Lane D.A., Weisel J.W., Grant P.J.",13690191,"Fibrinolysis and Proteolysis",14, 1,0,0,0,0,0,0
2000,"Methylenetetrahydrofolate reductase 677 C?T mutation and coronary heart disease risk in UK Indian Asians","Chambers J.C., Ireland H., Thompson E., Reilly P., Obeid O.A., Refsum H., Ueland P., Lane D.A., Kooner J.S.",10795642,"Arteriosclerosis, Thrombosis, and Vascular Biology",20, 11,18,2,5,7,3,28
2000,"Surfing the p53 network","Vogelstein B., Lane D., Levine A.J.",00280836,"Nature",408, 6810,1406,297,307,604,201,2211
2000,"The thrombomodulin gene mutation G127?A (Ala25Thr) and cerebrovascular disease","Warner D., Catto A., Kunz G., Ireland H., Grant P.J., Lane D.A.",10159770,"Cerebrovascular Diseases",10, 5,3,0,0,0,0,3
2000,"The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII affects cross-linked fibrin structure","Ariens R.A.S., Philippou H., Nagaswami C., Weisel J.W., Lane D.A., Grant P.J.",00064971,"Blood",96, 3,111,12,12,24,9,144
2000,"Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass","Philippou H., Adami A., Davidson S.J., Pepper J.R., Burman J.F., Lane D.A.",03406245,"Thrombosis and Haemostasis",84, 1,17,8,4,12,3,32
2000,"Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease","Lane D.A., Grant P.J.",00064971,"Blood",95, 5,273,23,28,51,11,335
2000,"Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes","Al-Obaidi M.K., Philippou H., Stubbs P.J., Adami A., Amersey R., Noble M.M., Lane D.A.",00097322,"Circulation",101, 4,45,9,5,14,0,59
2000,"Effect of Healon and Viscoat on outflow facility in human cadaver eyes","Lane D., Motolko M., Yan D.B., Ethier C.R.",08863350,"Journal of Cataract and Refractive Surgery",26, 2,3,0,0,0,1,4
2000,"Identification and characterization of a thrombomodulin gene mutation coding for an elongated protein with reduced expression in a kindred with myocardial infarction","Kunz G., Ireland H.A., Stubbs P.J., Kahan M., Coulton G.C., Lane D.A.",00064971,"Blood",95, 2,26,1,2,3,2,31
1999,"Determining exposure underreporting in pharmacoepidemiologic case-control studies: Methods and example","Lane D.A., Kramer M.S.",08954356,"Journal of Clinical Epidemiology",52, 12,0,0,0,0,0,0
1999,"Partition of the linear plasmid N15: Interactions of N15 partition functions with the sop locus of the F plasmid","Ravin N., Lane D.",00219193,"Journal of Bacteriology",181, 22,31,3,3,6,1,38
1999,"Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: Comparison with the structure of CD1/major histocompatibility complex ?1 and ?2 domains","Simmonds R.E., Lane D.A.",00064971,"Blood",94, 2,48,5,4,9,1,58
1999,"Familial overexpression of ? antithrombin caused by an Asn135Thr substitution","Bayston T.A., Tripodi A., Mannucci P.M., Thompson E., Ireland H., Fitches A.C., Hananeia L., Olds R.J., Lane D.A.",00064971,"Blood",93, 12,9,0,0,0,0,9
1999,"F VIIa and F1+2 in unstable angina pectoris: Heparin therapy, haemostatic activation and recurrent ischaemia","Amersey R., Stubbs P.J., Al Obaidi M., Adami A., Phillipou H., Lane D., Noble M.",13556037,"Heart",81, 1,0,0,0,0,0,0
1999,"Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53","Blattner C., Sparks A., Lane D.",02707306,"Molecular and Cellular Biology",19, 5,120,5,6,11,6,137
1999,"Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass: Relationship to increased thrombin generation and heparin concentration","Philippou H., Davidson S.J., Mole M.T., Pepper J.R., Burman J.F., Lane D.A.",10795642,"Arteriosclerosis, Thrombosis, and Vascular Biology",19, 2,13,2,2,4,2,19
1999,"The F plasmid centromere, sopC, is required for full repression of the sopAB operon","Yates P., Lane D., Biek D.P.",00222836,"Journal of Molecular Biology",290, 3,25,2,2,4,1,30
1998,"Impaired cotranslational processing as a mechanism for type I antithrombin deficiency","Fitches A.C., Appleby R., Lane D.A., De Stefano V., Leone G., Olds R.J.",00064971,"Blood",92, 12,10,1,0,1,0,11
1998,"The promise of molecular oncology","Lane D.",01406736,"Lancet",351, 2,19,0,1,1,0,20
1998,"A mutation in the thrombomodulin gene, 127G to a coding for Ala25Thr, and the risk of myocardial infarction in men","Doggen C.J.M., Kunz G., Rosendaal F.R., Lane D.A., Vos H.L., Stubbs P.J., Manger Cats V., Ireland H.",03406245,"Thrombosis and Haemostasis",80, 5,56,3,1,4,3,63
1998,"Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes","Stubbs P.J., Seed M., Lane D., Collinson P., Kendall F., Noble M.",0195668X,"European Heart Journal",19, 9,20,2,3,5,1,26
1998,"Awakening angels","Lane D.",00280836,"Nature",394, 6694,38,1,2,3,0,41
1998,"Early activation of the extrinsic pathway of coagulation in acute myocardial infarction and unstable angina pectoris","Amersey R., Stubbs P.J., Al Obaidi M., Adami A., Lane D., Noble M.I.M.",13556037,"Heart",79, 1,0,0,0,0,0,0
1998,"Aminorex, dexfenfluramine, and primary pulmonary hypertension","Kramer M.S., Lane D.A.",08954356,"Journal of Clinical Epidemiology",51, 4,9,3,2,5,3,17
1998,"Expression of the second lysine decarboxylate gene of Escherichia coli","Lemonnier M., Lane D.",13500872,"Microbiology",144, 3,14,0,0,0,2,16
1998,"Clarification of the risk for venous thrombosis associated with hereditary protein S deficiency by investigation of a large kindred with a characterized gene defect","Simmonds R.E., Ireland H., Lane D.A., Zoller B., Garcia De Frutos P., Dahlback B.",00034819,"Annals of Internal Medicine",128, 1,41,6,5,11,1,53
1997,"Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome","Nevard C.H.F., Jurd K.M., Lane D.A., Philippou H., Haycock G.B., Hunt B.J.",03406245,"Thrombosis and Haemostasis",78, 6,29,3,1,4,2,35
1997,"Genetic basis of the MbrC 'ploidy' phenotype in Echerichia coli","Estevenon A.-M., Lemonnier M., Rouquette C., Lane D.",00268925,"Molecular and General Genetics",256, 3,1,0,0,0,0,1
1997,"Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential","Mundt M., Hupp T., Fritsche M., Merkle C., Hansen S., Lane D., Groner B.",09509232,"Oncogene",15, 2,44,0,0,0,0,44
1997,"Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey I. Illustrative reference ranges by age, sex and hormone use","Lowe G.D.O., Rumley A., Woodward M., Morrison C.E., Philippou H., Lane D.A., Tunstall-Pedoe H.",00071048,"British Journal of Haematology",97, 4,111,8,10,18,7,136
1997,"Epidemiology of coagulation factors, inhibitors and activation markers: The Third Glasgow MONICA Survey II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease","Woodward M., Lowe G.D.O., Rumley A., Tunstall-Pedoe H., Philippou H., Lane D.A., Morrison C.E.",00071048,"British Journal of Haematology",97, 4,78,7,9,16,3,97
1997,"Antithrombin and its inherited deficiency states","Van Boven H.H., Lane D.A.",00371963,"Seminars in Hematology",34, 3,55,1,3,4,5,64
1997,"Antithrombin: Molecular basis of deficiency","Bayston T.A., Lane D.A.",03406245,"Thrombosis and Haemostasis",78, 1,29,3,2,5,3,37
1997,"Thrombomodulin gene mutations associated with myocardial infarction","Ireland H., Kunz G., Kyriakoulis K., Stubbs P.J., Lane D.A.",00097322,"Circulation",96, 1,89,2,3,5,1,95
1997,"Genetic and phenotypic analysis of a large (122-member) protein S- deficient kindred provides an explanation for the familial coexistence of type I and type III plasma phenotypes","Simmonds R.E., Zoller B., Ireland H., Thompson E., Garcia De Frutos P., Dahlback B., Lane D.A.",00064971,"Blood",89, 12,54,2,4,6,2,62
1997,"Protein S deficiency: A database of mutations","Gandrille S., Suzuki K., Formstone C., Cooper D.N., Espinosa Y., Sala N., Bernardi F., Aiach M., Borgel D., Ireland H., Lane D.A., Simmonds R., Reitsma P.H., Mannhalter C., Pabinger I., Saito H.",03406245,"Thrombosis and Haemostasis",77, 6,64,3,4,7,0,71
1997,"Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic action","Mukherjee M., Scully M.F., Kakkar V.V., Philippou H., Lane D.A., Jewitt D.",03406245,"Thrombosis and Haemostasis",77, 4,8,0,0,0,1,9
1997,"A novel specific immunoassay for plasma two-chain factor VIIa: Investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes","Philippou H., Adami A., Amersey R.A., Stubbs P.J., Lane D.A.",00064971,"Blood",89, 3,31,0,0,0,0,31
1997,"Erratum: Inherited thrombophilia: Part 2 (Thrombosis and Haemostasis (1996) 76(6) (824-834))","Lane D.A., Miletich J.P., Rosendaal F.R., Seligsohn U., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chandy M., Dahlback B., Ginter E.K.",03406245,"Thrombosis and Haemostasis",77, 5,1,0,0,0,0,1
1997,"Antithrombin Mutation Database: 2nd (1997) Update: For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","Lane D.A., Thein S.L., Emmerich J., Bayston T., Olds R.J., Fitches A.C., Cooper D.N., Millar D.S., Jochmans K., Perry D.J., Okajima K.",03406245,"Thrombosis and Haemostasis",77, 1,113,9,11,20,2,135
1996,"Two novel (R(- 11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds","Ireland H.A., Leone G., Finazzi G., Cohen H., Lane D.A., Boisclair M.D., Taylor J., Thompson E., Thein S.L., Girolami A., De Caterina M., Scopacasa F., De Stefano V.",10597794,"Human Mutation",7, 2,4,1,0,1,0,5
1996,"Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden","Rintelen C., Mannhalter C., Ireland H., Lane D.A., Knobl P., Lechner K., Pabinger I.",00071048,"British Journal of Haematology",93, 2,60,1,1,2,0,62
1996,"Identification of 19 protein S gene mutations in patients with phenotypic protein S deficiency and thrombosis","Simmonds R.E., Sas G., Tew C.J., Walker I.D., Ireland H., Kunz G., Lane D.A., Bhavnani M., Castaman G., Hambley H., Laffan M., O'Connor N.",00064971,"Blood",88, 11,25,2,1,3,0,28
1996,"Inherited thrombophilia: Part 2","Lane D.A., Miletich J.P., Rosendaal F.R., Seligsohn U., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chandy M., Dahlback B., Ginter E.K.",03406245,"Thrombosis and Haemostasis",76, 6,238,6,4,10,4,252
1996,"Gene mutations in 21 unrelated cases of phenotypic heterozygous protein C deficiency and thrombosis","Ireland H., Finazzi G., Halil O., Laffan M., Machin S., Woodcock B., Thompson E., Lane D.A., Chan L.C., Conard J., De Caterina M., Rocco V., De Stefano V., Leone G.",03406245,"Thrombosis and Haemostasis",76, 6,8,0,1,1,0,9
1996,"Inherited thrombophilia: Part 1","Lane D.A., Miletich J.P., Rosendaal F.R., Seligsohn U., Mannucci P.M., Bauer K.A., Bertina R.M., Bochkov N.P., Boulyjenkov V., Chandy M., Dahlback B., Ginter E.K.",03406245,"Thrombosis and Haemostasis",76, 5,424,17,11,28,16,468
1996,"Directed search for thrombomodulin gene mutations","Ireland H., Kyriakoulis K., Kunz G., Lane D.A.",03010147,"Haemostasis",26, 4,5,0,0,0,0,5
1996,"Prenatal diagnosis in combined antithrombin and factor V gene mutation","Lane D.A., Auberger K., Ireland H., Roscher A.A., Thein S.L.",00071048,"British Journal of Haematology",94, 4,5,0,0,0,0,5
1996,"High purity factor IX and prothrombin complex concentrate (PCC): Pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC","Philippou H., Adami A., Lane D.A., MacGregor I.R., Tuddenham E.G.D., Lowe G.D.O., Rumley A., Ludlam C.A.",03406245,"Thrombosis and Haemostasis",76, 1,33,1,1,2,0,35
1996,"Molecular genetics of antithrombin deficiency","Lane D.A., Kunz G., Olds R.J., Thein S.L.",0268960X,"Blood Reviews",10, 2,18,1,2,3,1,22
1996,"Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency","Van Boven H.H., Reitsma P.H., Rosendaal F.R., Bayston T.A., Chowdhury V., Bauer K.A., Scharrer I., Conard J., Lane D.A.",03406245,"Thrombosis and Haemostasis",75, 3,182,3,2,5,2,189
1995,"The CPSU ruling elite 1981-1991: Commonalities and divisions","Lane D., Ross C.",0967067X,"Communist and Post-Communist Studies",28, 3,2,0,0,0,0,2
1995,"Factor V Leiden gene mutation and thrombin generation in relation to the development of acute stroke","Catto A., Carter A., Ireland H., Bayston T.A., Philippou H., Barrett J., Lane D.A., Grant P.J.",10795642,"Arteriosclerosis, Thrombosis, and Vascular Biology",15, 6,101,3,2,5,4,110
1995,"An ELISA for factor X activation peptide: Application to the investigation of thrombogenesis in cardiopulmonary bypass","Philippou H., Adami A., Boisclair M.D., Lane D.A.",00071048,"British Journal of Haematology",90, 2,18,0,1,1,2,21
1995,"Factor V Leiden mutation and venous thrombosis [17]","Davies K.A., Ireland H., Athanassiou P., Loizou S., Lane D., Walport M.J., Ozsoylu S., Hatake K., Miura Y.",01406736,"Lancet",345, 8942,17,0,0,0,1,18
1995,"Prognostic significance of p53 overexpression in primary breast cancer; A novel luminometric immunoassay applicable on steroid receptor cytosols","Borg A., Brundell J., Lennerstrand J., Stenmark-Askmalm M., Ferno M., Brisfors A., Ohrvik A., Stal O., Killander D., Lane D.",00070920,"British Journal of Cancer",71, 5,54,1,0,1,0,55
1995,"Thrombotic risk during pregnancy and puerperium in women with APC-resistance - Effective subcutaneous heparin prophylaxis in a pregnant patient [1]","De Stefano V., Mastrangelo S., Paciaroni K., Ireland H., Lane D.A., Scirpa P., Bizzi B., Leone G.",03406245,"Thrombosis and Haemostasis",74, 2,33,2,0,2,0,35
1995,"Procoagulant triggers during cardiopulmonary bypass [2]","Tabuchi N., Van Oeveren W., Lane D.A., Biosclair M.D., Philippou H., Hunt B.J.",00064971,"Blood",85, 5,1,0,0,0,0,1
1995,"Apparent heterozygous type II protein C deficiency caused by the factor V 506 Arg to Gln mutation [4]","Ireland H., Bayston T., Thompson E., Adami A., Goncalves C., Lane D.A., Finazzi G., Barbui T.",03406245,"Thrombosis and Haemostasis",73, 4,11,0,0,0,1,12
1995,"Antithrombins Southport (Leu 99 to Val) and Vienna (Gln 118 to Pro): Two novel antithrombin variants with abnormal heparin binding","Chowdhury V., Mille B., Olds R.J., Lane D.A., Watton J., Barrowcliffe T.W., Pabinger I., Woodcock B.E., Thein S.L.",00071048,"British Journal of Haematology",89, 3,6,0,0,0,0,6
1994,"Hereditary antithrombin deficiency: Heterogeneity of the molecular basis and mortality in Dutch families","Van Boven H.H., Olds R.J., Thein S.-L., Reitsma P.H., Lane D.A., Briet E., Vandenbroucke J.P., Rosendaal F.R.",00064971,"Blood",84, 12,26,0,0,0,0,26
1994,"Role of N- and C-terminal amino acids in antithrombin binding to pentasaccharide","Mille B., Watton J., Barrowcliffe T.W., Mani J.-C., Lane D.A.",00219258,"Journal of Biological Chemistry",269, 47,21,0,1,1,2,24
1994,"Role of factor XII in thrombin generation and fibrinolysis during cardiopulmonary bypass","Burman J.F., Chung H.I., Lane D.A., Philippou H., Adami A., Lincoln J.C.R.",01406736,"Lancet",344, 8931,57,3,1,4,4,65
1994,"A polymorphism in the human coagulation factor V gene","Bayston T.A., Ireland H., Olds R.J., Thein S.L., Lane D.A.",09646906,"Human Molecular Genetics",3, 11,9,0,0,0,0,9
1994,"Induction of the SOS response by IS1 transposase","Lane D., Cavaille J., Chandler M.",00222836,"Journal of Molecular Biology",242, 4,22,1,2,3,1,26
1994,"Antithrombin III: Summary of first database update","Lane D.A., Olds R.J., Thein S.L.",03051048,"Nucleic Acids Research",22, 17,8,0,0,0,0,8
1994,"(ATT) trinucleotide repeats in the antithrombin gene and their use in determining the origin of repeated mutations","Olds R.J., Lane D.A., Chowdhury V., Sas G., Pabinger I., Auberger K., Thein S.L.",10597794,"Human Mutation",4, 1,13,0,0,0,0,13
1994,"Risk factors for cardiovascular disease in IDDM: A study of identical twins","Dubrey S.W., Reaveley D.R., Seed M., Lane D.A., Ireland H., O'Donnell M., O'Connor B., Noble M.I., Leslie R.D.G.",00121797,"Diabetes",43, 6,39,1,2,3,0,42
1994,"Antibody fragments from a 'single pot' phage display library as immunochemical reagents","Nissim A., Hoogenboom H.R., Tomlinson I.M., Flynn G., Midgley C., Lane D., Winter G.",02614189,"EMBO Journal",13, 3,332,15,11,26,6,364
1994,"Low affinity heparin is an antithrombotic agent","Gray E., Cesmell S., Lormeau J.C., Davies A.B., Lane D.A.",03406245,"Thrombosis and Haemostasis",71, 2,9,0,3,3,0,12
1994,"Nomenclature of quantities and units in thrombosis and haemostasis (Recommendation 1993). A collaborative project of the ISTH/SSC and the IUPAC-IFCC/CQU(CC)","Blomback M., Hoyer L.W., Johnson G.J., Kasper C., Lane D., Lijnen H.R., Lusher J.M., Mannucci P.M., Poller L., Rapaport S.I., Saito H., Abildgaard U., Van den Besselaar A.M.H.P., Clementson K.J., Dahlback B., Exner T., Francis C.W., Gaffney P., Gralnick H.",03406245,"Thrombosis and Haemostasis",71, 3,19,1,1,2,0,21
1994,"Neutralization of heparin by trasylol [3]","Lane D.A., MacGregor I.R., Preston F.E., Alston T.A., D'Ambra M.N.",00034975,"Annals of Thoracic Surgery",58, 2,1,0,0,0,0,1
1994,"Antithrombin: The principal inhibitor of thrombin","Olds R.J., Lane D.A., Mille B., Chowdhury V., Thein S.L.",00946176,"Seminars in Thrombosis and Hemostasis",20, 4,32,3,1,4,0,36
1994,"The molecular genetics of antithrombin deficiency","Olds R.J., Lane D.A., Thein S.L.",00071048,"British Journal of Haematology",87, 2,6,0,0,0,0,6
1994,"Is the IS1 transposase, InsAB', the only IS1-encoded protein required for efficient transposition?","Escoubas J.M., Lane D., Chandler M.",00219193,"Journal of Bacteriology",176, 18,4,0,0,0,1,5
1994,"The scientific basis for selection of measures of thrombogenicity","Lane D.A., Bowry S.K.",09310509,"Nephrology Dialysis Transplantation",9, 2,26,2,0,2,1,29
1994,"Microheterogeneity of antithrombin III: Effect of single amino acid substitutions and relationship with functional abnormalities","De Stefano V., Rodeghiero F., Bizzi B., Leone G., Mastrangelo S., Lane D.A., Girolami A., De Moerloose P., Sas G., Abildgaard U., Blajchman M.",09575235,"Blood Coagulation and Fibrinolysis",5, 1,0,0,0,0,0,0
1994,"Homozygous antithrombin deficiency: Report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis","Chowdhury V., Lane D.A., Mille B., Auberger K., Gandenberger-Bachem S., Pabinger I., Olds R.J., Thein S.L.",03406245,"Thrombosis and Haemostasis",72, 2,46,1,0,1,1,48
1993,"Omplete nucleotide sequence of the antithrombin gene: Evidence for homologous recombination causing thrombophilia","Olds R.J., Lane D.A., Chowdhury V., De Stefano V., Leone G., Thein S.L.",00062960,"Biochemistry",32, 16,56,2,2,4,0,60
1993,"Thrombogenic mechanisms in the human: Fresh insights obtained by immunodiagnostic studies of coagulation markers","Boisclair M.D., Philippou H., Lane D.A.",09575235,"Blood Coagulation and Fibrinolysis",4, 6,30,2,0,2,0,32
1993,"Artificial worlds and economics, part II","Lane D.A.",09369937,"Journal of Evolutionary Economics",3, 3,16,5,0,5,0,21
1993,"Artificial worlds and economics, part I","Lane D.A.",09369937,"Journal of Evolutionary Economics",3, 2,24,5,4,9,0,33
1993,"Information contagion","Arthur W.B., Lane D.A.",0954349X,"Structural Change and Economic Dynamics",4, 1,18,2,4,6,2,26
1993,"Non-anticoagulant uses of heparin","Lane D.A., Adams L.",00284793,"New England Journal of Medicine",329, 2,21,1,0,1,0,22
1993,"A recurrent deletion in the antithrombin gene, AT106-108(6 bp), identified by DNA heteroduplex detection","Olds R.J., Lane D.A., Beresford C.H., Abildgaard U., Hughes P.M., Thein S.L.",08887543,"Genomics",16, 1,5,1,0,1,0,6
1993,"Thrombin production, inactivation and expression during open heart surgery measured by assays for activation fragments including a new ELISA for prothrombin fragment Fe1+2","Boisclair M.D., Lane D.A., Philippou H., Sheikh S., Hunt B.",03406245,"Thrombosis and Haemostasis",70, 2,87,7,4,11,2,100
1993,"Identification of nine novel mutations in type I antithrombin deficiency by heteroduplex screening","Chowdhury V., Finazzi G., Castaman G., Mannucci P.M., Thein S.L., Olds R.J., Lane D.A., Conard J., Pabinger I., Ryan K., Bauer K.A., Bhavnani M., Abildgaard U.",00071048,"British Journal of Haematology",84, 4,25,0,0,0,0,25
1993,"Antithrombin III mutation database: First update. For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","Lane D.A., Aiach M., Olds R.J., Boisclair M., Chowdhury V., Thein S.L., Cooper D.N., Blajchman M., Perry D., Emmerich J.",03406245,"Thrombosis and Haemostasis",70, 2,71,0,1,1,1,73
1993,"p53 protein expression in benign and malignant skin tumours","Ro Y.S., Cooper P.N., Lee J.A., Quinn A.G., Harrison D., Lane D., Horne C.H.W., Rees J.L., Angus B.",00070963,"British Journal of Dermatology",128, 3,53,2,0,2,3,58
1993,"HPV-16 E7 or adenovirus E1A can overcome the growth arrest of cells immortalized with a temperature-sensitive p53","Vousden K.H., Vojtesek B., Fisher C., Lane D.",09509232,"Oncogene",8, 6,21,0,0,0,1,22
1993,"Mechanisms of thrombin generation during surgery and cardiopulmonary bypass","Boisclair M.D., Lane D.A., Philippou H., Esnouf M.P., Sheikh S., Hunt B., Smith K.J.",00064971,"Blood",82, 11,154,13,9,22,5,181
1993,"Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma","Pezzella F., Morrison H., Jones M., Gatter K.C., Lane D., Harris A.L., Mason D.Y.",03090167,"Histopathology",22, 1,70,1,0,1,0,71
1992,"A microtitre plate ELISA to measure thrombin-antithrombin complex using pan-specific antibodies","Boisclair M.D., Lane D.A.",09575235,"Blood Coagulation and Fibrinolysis",3, 6,3,0,0,0,0,3
1992,"Pleiotropic effects of antithrombin strand 1C substitution mutations","Lane D.A., Sas G., Horellou M.H., Tamponi G., Thein S.-L., Olds R.J., Conard J., Boisclair M., Bock S.C., Hultin M., Abildgaard U., Ireland H., Thompson E.",00219738,"Journal of Clinical Investigation",90, 6,31,2,1,3,1,35
1992,"Causal propositions in clinical research and practice","Kramer M.S., Lane D.A.",08954356,"Journal of Clinical Epidemiology",45, 6,14,1,1,2,0,16
1992,"Dermatan sulphate in haemodialysis","Lane D.A., Ryan K., Ireland H., Curtis J.R., Nurmohamed M.T., Krediet R.T., Roggekamp M.C., Stevens P., Ten Cate J.W.",01406736,"Lancet",339, 8789,14,0,1,1,0,15
1992,"Use of gel retardation to analyze protein-nucleic acid interactions","Lane D., Prentki P., Chandler M.",01460749,"Microbiological Reviews",56, 4,109,5,5,10,5,124
1992,"Antithrombotic properties of dermatan sulphate (MF 701) in haemodialysis for chronic renal failure","Ryan K.E., Lane D.A., Flynn A., Ireland H., Boisclair M., Shepperd J., Curtis J.R.",03406245,"Thrombosis and Haemostasis",68, 5,20,1,2,3,0,23
1992,"Over-expression of p53 nuclear oncoprotein in colorectal adenomas","Pignatelli M., Stamp G.W.H., Kafiri G., Lane D., Bodmer W.F.",00207136,"International Journal of Cancer",50, 5,44,0,1,1,0,45
1992,"Analysis of p53 expression in human tumours: An antibody raised against human p53 expressed in Escherichia coli","Midgley C.A., Fisher C.J., Bartek J., Vojtesek B., Lane D., Barnes D.M.",00219533,"Journal of Cell Science",101, 1,138,1,2,3,0,141
1992,"Antithrombin III Budapest: A single amino acid substitution (429Pro to Leu) in a region highly conserved in the serpin family","Olds R.J., Lane D.A., Caso R., Panico M., Morris H.R., Sas G., Dawes J., Thein S.L.",00064971,"Blood",79, 5,10,0,0,0,0,10
1992,"The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot","Schlichtholz B., Legros Y., Gillet D., Gaillard C., Marty M., Lane D., Calvo F., Soussi T.",00085472,"Cancer Research",52, 22,195,7,6,13,1,209
1992,"The relationship of p53 immunostaining to survival in carcinoma of the lung","McLaren R., Kuzu I., Dunnill M., Harris A., Lane D., Gatter K.C.",00070920,"British Journal of Cancer",66, 4,117,0,2,2,0,119
1992,"Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F","Olds R.J., Lane D.A., Boisclair M., Sas G., Bock S.C., Thein S.L.",00145793,"FEBS Letters",300, 3,9,2,0,2,0,11
1992,"Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma","Eccles D.M., Brett L., Lessells A., Gruber L., Lane D., Steel C.M., Leonard R.C.F.",00070920,"British Journal of Cancer",65, 1,52,1,1,2,1,55
1992,"Antithrombin and its deficiency states","Lane D.A., Olds R.R., Thein S.-L.",09575235,"Blood Coagulation and Fibrinolysis",3, 3,23,1,0,1,0,24
1991,"A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (ARG to STOP)","Olds R.J., Lane D.A., Ireland H., Finazzi G., Barbui T., Abildgaard U., Girolami A., Thein S.L.",00493848,"Thrombosis Research",64, 5,5,0,0,0,0,5
1991,"Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer","Horak E., Smith K., Bromley L., LeJeune S., Greenall M., Lane D., Harris A.L.",09509232,"Oncogene",6, 12,43,0,0,0,1,44
1991,"Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate","Caso R., Aiach M., Rodeghiero F., Finazzi G., Lane D.A., Thompson E.A., Olds R.J., Thein S.L., Panico M., Blench I., Morris H.R., Freyssinet J.M.",00071048,"British Journal of Haematology",77, 1,5,0,0,0,1,6
1991,"Antithrombin Glasgow II: Alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin","Ireland H., Thein S.L., Lane D.A., Thompson E., Walker I.D., Blench I., Morris H.R., Freyssinet J.M., Grunebaum L., Olds R.",00071048,"British Journal of Haematology",79, 1,8,0,0,0,0,8
1991,"The pharmacokinetics of dermatan sulphate MF701 in healthy human volunteers","Dawes J., McLaren M., Forbes C., Belch J.J.F., Lane D.A., Bray B., McEwen J., Houin G., Gianese F.",03065251,"British Journal of Clinical Pharmacology",32, 3,13,0,1,1,1,15
1991,"Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis","Ryan K.E., Lane D.A., Flynn A., Shepperd J., Ireland H.A., Curtis J.R.",03406245,"Thrombosis and Haemostasis",66, 3,18,0,1,1,2,21
1991,"Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation","Ireland H.A., Boisclair M.D., Lane D.A., Thompson E., Curtis J.R.",03010430,"Clinical Nephrology",35, 1,4,1,0,1,1,6
1991,"Novel point mutations leading to type 1 antithrombin deficiency and thrombosis","Olds R.J., Lane D.A., Ireland H., Leone G., De Stefano V., Wiesel M.L., Cazenave J.-P., Thein S.L.",00071048,"British Journal of Haematology",78, 3,7,0,0,0,0,7
1991,"Antithrombin III: A database of mutations","Lane D.A., Ireland H., Olds R.J., Thein S.L., Perry D.J., Aiach M.",03406245,"Thrombosis and Haemostasis",66, 6,16,0,1,1,2,19
1990,"The Bayesian differential diagnosis of neutropenia associated with antiarrhythmic agents","Naranjo C.A., Lanctot K.L., Lane D.A.",00912700,"Journal of Clinical Pharmacology",30, 12,10,0,1,1,0,11
1990,"Antithrombin Padua I: Impaired heparin binding caused by an Arg 47 to His (CGT to CAT) substitution","Caso R., Lane D.A., Thompson E., Zangouras D., Panico M., Morris H., Olds R.J., Thein S.L., Girolami A.",00493848,"Thrombosis Research",58, 2,2,1,0,1,0,3
1990,"Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing","Olds R.J., Lane D.A., Caso R., Girolami A., Thein S.-L.",03051048,"Nucleic Acids Research",18, 7,1,0,0,0,0,1
1990,"Assessment of hypercoagulable states by measurement of activation fragments and peptides","Boisclair M.D., Ireland H., Lane D.A.",0268960X,"Blood Reviews",4, 1,44,0,3,3,3,50
1990,"The elderly on dialysis: Some considerations in compliance","McKevitt P.M., Jones J.F., Lane D.A., Marion R.R.",02726386,"American Journal of Kidney Diseases",16, 4,9,0,0,0,0,9
1990,"A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: Prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparin","Anastassiades E., Ireland H., Flynn A., Lane D.A., Curtis J.R.",09310509,"Nephrology Dialysis Transplantation",5, 2,20,1,0,1,1,22
1990,"The importance of anti-factor Xa and antithrombin activities of low molecular weight heparins","Lane D.A., Ryan K.",00222143,"Journal of Laboratory and Clinical Medicine",116, 2,1,0,0,0,0,1
1990,"A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: Thrombin-antithrobmin complex, D-dimer and fibrinogen/fibrin fragment E antigen","Boisclair M.D., Lane D.A., Wilde J.T., Ireland H., Preston F.E., Ofosu F.A.",00071048,"British Journal of Haematology",74, 4,30,1,1,2,0,32
1990,"A frameshift mutation leading to type 1 antithrombin deficiency and thrombosis","Olds R.J., Lane D.A., Finazzi G., Barbui T., Thein S.-L.",00064971,"Blood",76, 11,5,0,0,0,0,5
1990,"A Bayesian assessment of idiosyncratic adverse reactions to new drugs: Guillain-Barre syndrome and zimeldine","Naranjo C.A., Lane D., Ho-Asjoe M., Lanctot K.L.",00912700,"Journal of Clinical Pharmacology",30, 2,8,0,1,1,0,9
1989,"A low molecular weight heparin ('fragmin') for routine hemodialysis: A crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin","Anastassiades E., Lane D.A., Ireland H., Flynn A., Curtis J.R.",03010430,"Clinical Nephrology",32, 6,14,0,0,0,1,15
1989,"Antithrombin III Milano 2: A single base substitution in the thrombin binding domain detected with PCR and direct genomic sequencing","Olds R.J., Lane D., Caso R., Tripodi A., Mannucci P.M., Thein S.-L.",03051048,"Nucleic Acids Research",17, 24,1,0,0,0,0,1
1989,"Autoregulation of the ccd operon in the F plasmid","de Feyter R., Wallace C., Lane D.",00268925,"MGG Molecular & General Genetics",218, 3,25,2,1,3,0,28
1989,"A Bayesian approach for evaluating severe adverse events associated with new drugs: Guillain-Barre syndrome and zimelidine","Naranjo C.A., Lanctot K.L., Ho-Asjoe M., Lane D.",,"Recent advances in pharmacology and therapeutics: proceedings of the XII Latin-American Congress of Pharmacology and the III Inter-American Congress of Clinical Pharmacology and Therapeutics. ICS839",, ,0,0,0,0,0,0
1989,"Heparin neutralizing proteins in blood","Lane D.A.",00778923,"Annals of the New York Academy of Sciences",556, ,0,0,0,0,0,0
1989,"Antithrombin: Structure, genomic organization, function and inherited deficiency","Lane D.A., Caso R.",09503536,"Bailliere's Clinical Haematology",2, 4,23,2,0,2,0,25
1989,"Heparin and low molecular weight heparin: Is anti-factor Xa activity important?","Lane D.A., Ryan K.",00222143,"Journal of Laboratory and Clinical Medicine",114, 4,1,0,0,0,0,1
1989,"Assessing methods for causality assessment of suspected adverse drug reactions","Hutchinson T.A., Lane D.A.",08954356,"Journal of Clinical Epidemiology",42, 1,25,3,3,6,1,32
1989,"A novel amino acid substitution in the reactive site of a congenital variant antithrombin. Antithrombin Pescara, Arg393 to Pro, caused by CGT to CCT mutation","Lane D.A., Erdjument H., Thompson E., Panico M., Di Marzo V., Morris H.R., Leone G., De Stefano V., Thein S.L.",00219258,"Journal of Biological Chemistry",264, 17,8,0,0,0,0,8
1989,"Assessing causality of adverse events in postmarketing surveillance: Bayesian evaluation of a case","Naranjo C.A., Lanctot K.L., Ho-Asjoe M., Lane D.",,"Recent advances in pharmacology and therapeutics: proceedings of the XII Latin-American Congress of Pharmacology and the III Inter-American Congress of Clinical Pharmacology and Therapeutics. ICS839",, ,0,0,0,0,0,0
1989,"Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin","Bray B., Lane D.A., Freyssinet J.-M., Pejler G., Lindahl U.",02646021,"Biochemical Journal",262, 1,15,2,1,3,1,19
1989,"Should blood cultures be obtained in the evaluation of young febrile children without evident focus of bacterial infection? A decision analysis of diagnostic management strategies","Kramer M.S., Lane D.A., Mills E.L.",00314005,"Pediatrics",84, 1,12,0,0,0,0,12
1989,"Heparin and low molecular weight heparin(oid)s as anticoagulants in hemodialysis for chronic renal failure","Lane D.A., Tew C., Ireland H., Flynn A., Curtis J.",00778923,"Annals of the New York Academy of Sciences",556, ,0,0,0,0,0,0
1989,"Antithrombin Chicago, amino acid substitution of arginine 393 to histidine","Erdjument H., Lane D.A., Panico M., Di Marzo V., Morris H.R., Bauer K., Rosenberg R.D.",00493848,"Thrombosis Research",54, 6,4,0,0,0,0,4
1989,"Antithrombin Sheffield: amino acid substitution at the reactive site (Arg393 to His) causing thrombosis","Lane D.A., Erdjument H., Flynn A., Di Marzo V., Panico M., Morris H.R., Greaves M., Dolan G., Preston F.E.",00071048,"British Journal of Haematology",71, 1,6,0,0,0,0,6
1989,"Plasma D dimer: A useful marker of fibrin breakdown in renal failure","Gordge M.P., Faint R.W., Rylance P.B., Ireland H., Lane D.A., Neild G.H.",03406245,"Thrombosis and Haemostasis",61, 3,9,1,1,2,2,13
1989,"The effect of heparin on the inositol 1,4,5-trisphosphate receptor in rat liver microsomes. Dependence on sulphate content and chain length","Tones M.A., Bootman M.D., Higgins B.F., Lane D.A., Pay G.F., Lindahl U.",00145793,"FEBS Letters",252, 1-2,27,3,1,4,0,31
1989,"Adverse events following immunization: Assessing probability of causation","Fenichel G.M., Lane D.A., Livengood J.R., Horwitz S.J., Menkes J.H., Schwartz J.F.",08878994,"Pediatric Neurology",5, 5,5,0,1,1,0,6
1988,"Response","Lane D.A., Hutchinson T.",08954356,"Journal of Clinical Epidemiology",41, 9,0,0,0,0,0,0
1988,"The international agranulocytosis and aplastic anemia study (IAAAS)","Kramer M.S., Lane D.A., Hutchinson T.A.",08954356,"Journal of Clinical Epidemiology",41, 6,4,0,1,1,0,5
1988,"Antithrombin Milano, single amino acid substitution at the reactive site, Arg393 to Cys","Erdjument H., Lane D.A., Ireland H., Di Marzo V., Panico M., Morris H.R., Tripodi A., Mannucci P.M.",03406245,"Thrombosis and Haemostasis",60, 3,6,0,0,0,0,6
1988,"A replication region of the IncHI plasmid, R27, is highly homologous with the RepFIA replicon of F.","Saul D., Lane D., Bergquist P.L.",0950382X,"Molecular microbiology",2, 2,6,0,0,0,0,6
1988,"Use of synthetic oligonucleotides in the characterization of antithrombin III Northwick Park (393 CGT ? TGT) and antithrombin III Glasgow (393 CGT ? CAT)","Thein S.L., Lane D.A.",00064971,"Blood",72, 5,1,0,0,0,0,1
1988,"Mapping and regulation of the pifC promoter of the F plasmid","Kennedy M., Chandler M., Lane D.",01674781,"Biochimica et Biophysica Acta - Gene Structure and Expression",950, 1,3,0,0,0,0,3
1988,"Relationship between anticoagulant activities and polyanionic properties of rabbit thrombomodulin","Bourin M.-C., Ohlin A.-K., Lane D.A., Stenflo J., Lindahl U.",00219258,"Journal of Biological Chemistry",263, 17,28,5,0,5,0,33
1988,"Acquired dysfibrinogenaemia masquerading as disseminated intravascular coagulation in acute pancreatitis","Wilde J.T., Thomas W.E.G., Lane D.A., Greaves M., Preston F.E.",00219746,"Journal of Clinical Pathology",41, 6,5,0,1,1,0,6
1988,"Low molecular weight heparin in haemodialysis for chronic renal failure: Dose finding study of CY222","Ireland H., Lane D.A., Flynn A., Pegrum A.C., Curtis J.R.",03406245,"Thrombosis and Haemostasis",59, 2,5,0,0,0,0,5
1988,"Single amino acid substitutions in the reactive site of antithrombin leading to thrombosis. Congenital substitution of arginine 393 to cysteine in antithrombin Northwick Park and to histidine in antithrombin Glasgow","Erdjument H., Lane D.A., Panico M., Di Marzo V., Morris H.R.",00219258,"Journal of Biological Chemistry",263, 12,15,0,0,0,0,15
1988,"Relationship between ex vivo and anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222","Tew C.J., Lane D.A., Thompson E., Ireland H., Curtis J.R.",00071048,"British Journal of Haematology",70, 3,4,0,0,0,0,4
1988,"Equivalent effective doses of heparin and low molecular weight heparin(oid)s in haemodialysis for chronic renal failure","Lane D.A., Ireland H., Tew C.J., Flynn A., Curtis J.R.",00015482,"Acta Chirurgica Scandinavica",154, 543,0,0,0,0,0,0
1988,"Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: Influence of inhibitors of fibrin polymerization","Ruf W., Bender A., Lane D.A., Preissner K.T., Selmayr E., Muller-Berghaus G.",03044165,"Biochimica et Biophysica Acta - General Subjects",965, 2-3,14,3,1,4,1,19
1987,"Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology","Kramer M.S., Lane D.A., Hutchinson T.A.",00219681,"Journal of Chronic Diseases",40, 12,8,0,1,1,0,9
1987,"Personality and antisocial behaviour: A long-term study","Lane D.A.",01918869,"Personality and Individual Differences",8, 6,14,2,0,2,1,17
1987,"Structural requirements for neutralization of heparin-like saccharides by complement S protein/vitronectin","Lane D.A., Flynn A.M., Pejler G., Lindahl U., PReissner K.",00219258,"Journal of Biological Chemistry",262, 34,12,1,0,1,0,13
1987,"The causality assessment of adverse drug reactions using a Bayesian approach","Lane D.A., Kramer M.S., Hutchinson T.A., Jones J.K., Naranjo C.",02650673,"Pharmaceutical Medicine",2, 3,19,0,2,2,0,21
1987,"Coordinate expression of the endogenous p53 gene in beta cells of transgenic mice expressing hybrid insulin-SV40 T antigen genes.","Efrat S., Baekkeskov S., Lane D., Hanahan D.",02614189,"EMBO Journal",6, 9,11,0,0,0,1,12
1987,"Postmarketing management of drug use: toward rational public policy.","Spitzer W.O., Hutchinson T., Lane D.",08203946,"CMAJ : Canadian Medical Association journal = journal de l""Association medicale canadienne",136, 10,0,0,0,0,0,0
1987,"The notion of 'acceptable risk': The role of utility in drug management","Lane D.A., Hutchinson T.A.",00219681,"Journal of Chronic Diseases",40, 6,5,0,0,0,0,5
1987,"Analysis of the F plasmid centromere","Lane D., Rothenbuehler R., Merrillat A.-M., Aiken C.",00268925,"Molecular and General Genetics",207, 2-3,15,1,0,1,0,16
1987,"Antithrombin III Glasgow: A variant with increase heparin affinity and reduced ability to inactivate thrombin, associated with familial thrombosis","Lane D.A., Lowe G.D.O., Flynn A., Thompson E., Ireland H., Erdjument H.",00071048,"British Journal of Haematology",66, 4,6,0,0,0,0,6
1987,"Utility, decision, and quality of life","Lane D.A.",00219681,"Journal of Chronic Diseases",40, 6,11,1,0,1,0,12
1987,"Formation of a covalent disulfide-linked antithrombin-albumin complex by an antithrombin variant, antithrombin 'Northwick Park'","Erdjument H., Lane D.A., Ireland H.",00219258,"Journal of Biological Chemistry",262, 28,9,0,0,0,0,9
1987,"Antithrombin III Northwick Park: Demonstration of an inactive high MW complex with increased affinity for heparin","Lane D.A., Flynn A., Ireland H.",00071048,"British Journal of Haematology",65, 4,2,0,0,0,0,2
1987,"Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography: Investigation of nine congenital fibrinogen abnormalities","Southan C., Thompson E., Lane D.A.",00071048,"British Journal of Haematology",65, 4,1,0,0,0,0,1
1986,"D protein of miniF plasmid acts as a repressor of transcription and as a site-specific resolvase.","Lane D., de Feyter R., Kennedy M., Phua S.H., Semon D.",03051048,"Nucleic Acids Research",14, 24,15,0,0,0,0,15
1986,"A Bayesian approach to causality assessment for adverse drug reactions: Analysis of a case of exfoliative dermatitis","Kramer M.S., Hutchinson T.A., Lane D.A.",00928615,"Drug Information Journal",20, 4,0,0,0,0,0,0
1986,"The logic of uncertainty: Measuring degree of belief","Lane D.A.",00928615,"Drug Information Journal",20, 4,2,0,0,0,0,2
1986,"Neutralization of heparin-rich saccharides by histidine-rich glycoprotein and platelet factor 4","Lane D.A., Pejler G., Flynn A.M.",00219258,"Journal of Biological Chemistry",261, 9,65,3,2,5,0,70
1986,"The Bayesian approach to causality assessment: An introduction","Lane D.A.",00928615,"Drug Information Journal",20, 4,5,0,0,0,0,5
1986,"Direct analysis of plasma fibrinogen-derived fibrinopeptides by high performance liquid chromatography: Investigation of A?-chain N-terminal heterogeneity","Southan C., Thompson E., Lane D.A.",03406245,"Thrombosis and Haemostasis",56, 2,1,0,0,0,1,2
1986,"Haemodialysis with low MW heparin: Dosage requirements for the elimination of extracorporeal fibrin formation","Lane D.A., Ireland H., Flynn A., Anastassiades E., Curtis J.R.",09310509,"Nephrology Dialysis Transplantation",1, 3,2,0,0,0,0,2
1986,"Standardized methods of causality assessment for suspected adverse drug reactions","Hutchinson T.A., Lane D.A.",00219681,"Journal of Chronic Diseases",39, 11,1,0,0,0,0,1
1986,"On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure","Lane D.A., Flynn A., Ireland H.",03010147,"Haemostasis",16, 2,9,0,0,0,0,9
1986,"The anticoagulant effect of heparinoid Org 10 172 during haemodialysis: An objective assessment","Ireland H., Lane D.A., Flynn A.",03406245,"Thrombosis and Haemostasis",55, 2,12,0,0,0,0,12
1986,"Direct analysis of plasma fibrinogen-derived fibrinopeptides by high-performance liquid chromatography","Southan C., Thompson E., Lane D.A.",00493848,"Thrombosis Research",43, 2,1,0,0,0,0,1
1985,"Genes for phaseolotoxin synthesis are located on the chromosome of Pseudomonas syringae pv. phaseolicola","Quigley N.B., Lane D., Bergquist P.L.",03438651,"Current Microbiology",12, 5,1,0,0,0,0,1
1985,"A sensitive latex slide assay for fibrin(ogen) fragment E","Carney J.A., Knight I., Lane D.A.",00098981,"Clinica Chimica Acta",147, 2,0,0,0,0,0,0
1985,"Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool","Southan C., Lane D.A., Knight I.",02646021,"Biochemical Journal",229, 3,0,0,0,0,0,0
1985,"Location of rep and inc sequences in the F secondary replicon","Gardner R., McAnulty J., Feher E., Lane D.",0147619X,"Plasmid",13, 2,0,0,0,0,0,0
1985,"Reply","Lane D.A., Ireland H., Curtis J.R.",00222143,"The Journal of Laboratory and Clinical Medicine",105, 1,0,0,0,0,0,0
1985,"Specific identification of fibrin polymers, fibrinogen degradation products, and crosslinked fibrin degradation products in plasma and serum with a new sensitive technique","Connaghan D.G., Francis C.W., Lane D.A., Marder V.J.",00064971,"Blood",65, 3,5,0,0,0,0,5
1985,"Haemodialysis with prostacyclin (Epoprostenol) alone.","Rylance P.B., Gordge M.P., Ireland H., Lane D.A., Weston M.J.",03089401,"Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress",21, ,2,0,0,0,0,2
1985,"Analysis of a region in plasmid R386 containing two functional replications","Robinson P., Bergquist P., Lane D.",0147619X,"Plasmid",14, 1,0,0,0,0,0,0
1985,"Fibrinogen derivatives and platelet activation products in acute and chronic liver disease","Hughes R.D., Lane D.A., Ireland H.",01435221,"Clinical Science",68, 6,5,0,0,0,0,5
1985,"Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16 > His substitution","Southan C., Lane D.A., Bode W., Henschen A.",00142956,"European Journal of Biochemistry",147, 3,3,0,0,0,0,3
1984,"The mini-F primary origin. Sequence analysis and multiple activities","Lane D., Hill D., Caughey P., Gunn P.",00222836,"Journal of Molecular Biology",180, 2,1,0,0,0,0,1
1984,"Objective assessment of heparin requirements for hemodialysis in humans","Ireland H., Lane D.A., Curtis J.R.",00222143,"Journal of Laboratory and Clinical Medicine",103, 4,5,1,0,1,0,6
1984,"Experimental evidence for renal catabolism of fibrin fragment ?15-42","Lane D.A., Markwick J., Thompson E., Ireland H.",00493848,"Thrombosis Research",33, 6,0,0,0,0,0,0
1984,"The significance of fibrinogen derivatives in plasma in human renal failure","Lane D.A., Ireland H., Knight I.",00071048,"British Journal of Haematology",56, 2,8,1,1,2,1,11
1984,"Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4","Lane D.A., Denton J., Flynn A.M.",02646021,"Biochemical Journal",218, 3,102,4,3,7,3,112
1984,"Detection of enhanced in vivo platelet ?-granule release in different patient groups - Comparison of ?-thromboglobulin, platelet factor 4 and thrombospondin assays","Lane D.A., Ireland H., Wolff S.",03406245,"Thrombosis and Haemostasis",52, 2,13,0,0,0,1,14
1983,"Binding of platelet factor 4 to heparin oligosaccharides","Denton J., Lane D.A., Thunberg L.",02646021,"Biochemical Journal",209, 2,18,2,0,2,3,23
1983,"A cryptic plasmid from Shigella sonnei","Croft J.E., Bergquist P.L., Lane D.",00221287,"Journal of General Microbiology",129, 5,1,0,0,0,0,1
1983,"Fibrinogen Manchester: Identification of an abnormal fibrinopeptide A with a C-terminal arginine?histidine substitution","Southan C., Kehl M., Henschen A., Lane D.A.",00071048,"British Journal of Haematology",54, 1,0,0,0,0,0,0
1983,"Delayed release of an abnormal fibrinopeptide A from fibrinogen Manchester: Effect of the A? 16 Arg?His substitution upon fibrin monomer polymerization and the immunological crossreactivity of the peptide","Lane D.A., Southan C., Ireland H.",00071048,"British Journal of Haematology",53, 4,1,0,0,0,0,1
1983,"Activation of coagulation and fibrinolytic systems following stroke","Lane D.A., Wolff S., Ireland H.",00071048,"British Journal of Haematology",53, 4,11,0,0,0,0,11
1982,"Two more abnormal fibrinogens (London III and Sydney) with impaired fibrinopeptide release","Lane D.A., Ireland H., Thompson E.",00493848,"Thrombosis Research",28, 6,0,1,0,1,0,1
1982,"The prediction of delinquency: a correlation between a measure of personality and classroom behaviour","Lane D.A., Hymans M.H.",01918869,"Personality and Individual Differences",3, 1,0,0,0,0,0,0
1982,"Plasma concentrations of fibrinopeptide A, fibrinogen fragment B?1-42 and ?-thromboglobulin following total hip replacement","Lane D.A., Ireland H., Wolff S.",00493848,"Thrombosis Research",26, 2,6,0,0,0,0,6
1982,"Proteolysis of fibrinogen in healthy volunteers following major and minor in vivo plasminogen activation","Prowse C.V., Dawes J., Lane D.A.",00493848,"Thrombosis Research",27, 1,0,0,0,0,0,0
1982,"Cellular proteins reactive with monoclonal antibodies directed against simian virus 40 T-antigen","Crawford L., Leppard K., Lane D., Harlow E.",0022538X,"Journal of Virology",42, 2,15,2,3,5,1,21
1982,"Clearance of human desaminotyrosyl fibrinopeptide A from the rat circulation: Role of kidney and proteolytic enzymes","Lane D.A., Siodlak M., Thompson E., Allen-Mersh T.G.",00493848,"Thrombosis Research",26, 2,1,0,0,0,0,1
1982,"In vivo platelet release in myeloproliferative disorders","Ireland H., lane D.A., Wolff S., Foadi M.",03406245,"Thrombosis and Haemostasis",48, 1,6,0,0,0,0,6
1981,"Fibrinogen derivatives in plasma","Lane D.A.",00071048,"British Journal of Haematology",47, 3,3,0,0,0,0,3
1981,"The empirical distribution of the fourier coefficients of a sequence of independent, identically distributed long-tailed random variables","Freedman D., Lane D.",00443719,"Zeitschrift fr Wahrscheinlichkeitstheorie und Verwandte Gebiete",58, 1,3,1,0,1,0,4
1980,"The heparin-accelerated neutralisation of bovine ? and ? thrombins by antithrombin III","MacGregor I.R., Lane D.A., Kakkar V.V.",00063002,"Biochimica et Biophysica Acta",632, 1,0,0,0,0,0,0
1980,"The anti-heparin properties of human low-density lipoprotein","MacGregor I.R., Lane D.A., Kakkar V.V.",00063002,"Biochimica et Biophysica Acta",617, 3,0,0,0,0,0,0
1980,"Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell","Hanahan D., Lane D., Lipsich L.",,"Cell",21, 1,19,0,0,0,2,21
1980,"Dysfibrinogenaemia characterized by abnormal fibrin monomer polymerization and normal fibrinopeptide A release","Lane D.A., Cuddigan B., VanRoss M., Kakkar V.V.",00071048,"British Journal of Haematology",44, 3,2,0,0,0,0,2
1980,"Replication mutants of the F-plasmid of Escherichia coli. II. Cloned replication regions of temperature-sensitive mutants","Gardner R.C., Caughey P.A., Lane D., Bergquist P.L.",0147619X,"Plasmid",3, 2,1,0,0,0,0,1
1980,"Replication mutants of the F-plasmid of Escherichia coli K-12. I. Isolation and characterization of temperature-sensitive replication mutants of F'-gal+","Bergquist P.L., Jamieson A.F., Gardner R.C., Lane D.",0147619X,"Plasmid",3, 2,0,0,0,0,0,0
1980,"The neutralisation of heparin by trasylol","Davies R.J., Lane D.A., McGregor I.R., Preston F.E.",00493848,"Thrombosis Research",17, 3-4,1,0,0,0,0,1
1980,"An abnormal fibrinogen with delayed fibrinopeptide A release","Lane D.A., VanRoss M., Kakkar V.V.",00071048,"British Journal of Haematology",46, 1,1,0,0,0,0,1
1980,"Platelet function during haemoperfusion in acute liver failure","Hughes R.D., Lane D.A., Cella G.",03913988,"International Journal of Artificial Organs",3, 1,0,1,0,1,0,1
1979,"Administration of fractionated heparins to man","Lane D.A., MacGregor I.R., Cella G., Kakkar V.V.",03406245,"Thrombosis and Haemostasis",42, 1,0,0,0,0,0,0
1979,"Purine salvage at the cholinergic nerve endings of the Torpedo electric organ: The central role of adenosine","Zimmermann H., Dowdall M.J., Lane D.A.",03064522,"Neuroscience",4, 7,8,0,1,1,0,9
1979,"Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III","MacGregor I.R., Lane D.A., Kakkar V.V.",00063002,"Biochimica et Biophysica Acta",586, 3,1,0,1,1,0,2
1979,"Molecular weight dependence of the anticoagulant properties of heparin: Intravenous and subcutaneous administration of fractionated heparins to man","Lane D.A., MacGregor I.R., VanRoss M.",00493848,"Thrombosis Research",16, 5-6,6,0,0,0,0,6
1979,"Second EcoRI fragment of F capable of self-replication","Lane D., Gardner R.C.",00219193,"Journal of Bacteriology",139, 1,5,0,0,0,1,6
1978,"Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation","Lane D.A., Preston F.E., Van Ross M.E., Kakkar V.V.",00071048,"British Journal of Haematology",40, 4,14,0,0,0,1,15
1978,"Neutralization of heparin in plasma by platelet factor 4 and protamine sulfate","Michalski R., Lane D.A., Pepper D.S., Kakkar V.V.",00071048,"British Journal of Haematology",38, 4,3,0,1,1,0,4
1978,"The relationship between molecular weight and specific activity of unfractionated and fractionated heparins","MacGregor I.R., Lane D.A., Kakkar V.V.",03005127,"Biochemical Society Transactions",6, 1,0,0,0,0,0,0
1978,"Methodological advances in the detection of fibrinogen and fibrin degradation products (FDP)","Lane D.A.",00411787,"Trasfusione del Sangue",23, 3,0,0,0,0,0,0
1978,"Anticoagulant activities of four unfractionated and fractionated heparins","Lane D.A., Macgregor I.R., Michalski R., Kakkar V.V.",00493848,"Thrombosis Research",12, 2,8,0,1,1,0,9
1977,"Comparison of heparin and a semi synthetic heparin analogue, A73025. I. Kinetics of clearance from the circulation of man following intravenous injection","Lane D.A., Michalski R., Van Ross M.E., Kakkar V.V.",00071048,"British Journal of Haematology",37, 2,5,0,0,0,0,5
1977,"Absorption of different salts of heparin following subcutaneous injection","Cella G., Lane D.A., MacGregor I., Kakkar V.V.",03406245,"Thrombosis and Haemostasis",38, 1,0,0,0,0,0,0
1977,"The kinetics of clearance from the circulation of man and a semi-synthetic heparin analogue","Lane D.A., Michalski R., Kakkar V.V.",03406245,"Thrombosis and Haemostasis",38, 1,0,0,0,0,0,0
1977,"Platelet factor 4 (PF4) and protamine neutralisation of heparin in plasma","Michalski R., Lane D.A., Pepper D., Kakkar V.V.",03406245,"Thrombosis and Haemostasis",38, 1,0,0,0,0,0,0
1977,"Comparison of heparin and a semi synthetic heparin analogue, A73025. II. Some effects on platelet function","Michalski R., Lane D.A., Kakkar V.V.",00071048,"British Journal of Haematology",37, 2,4,0,0,0,0,4
1977,"A comparative study of the effects of heparin and a low molecular weight semi-synthetic heparin analogue upon platelet function","Michalski R., Lane D.A., Kakkar V.V.",03406245,"Thrombosis and Haemostasis",38, 1,0,0,0,0,0,0
1977,"SDS polyacrylamide gel characterization of serum FDP produced in response to ancrod and streptokinase/plasminogen infusions in man","Lane D.A., Robbins P.A., Rampling M.W., Kakkar V.V.",00071048,"British Journal of Haematology",36, 1,2,0,0,0,0,2
1977,"Intermittent plasminogen streptokinase treatment of deep vein thrombosis","Scully M.F., Lane D.A., Sagar S.",03406245,"Thrombosis and Haemostasis",37, 1,1,0,0,0,0,1
1977,"A heparin analogue with specific action on antithrombin III","Thomas D.P., Lane D.A., Michalski R.",01406736,"Lancet",1, 8003,6,0,0,0,0,6
1977,"Acquired dysfibrinogenaemia in acute and chronic liver disease","Lane D.A., Scully M.F., Thomas D.P.",00071048,"British Journal of Haematology",35, 2,8,1,0,1,0,9
1976,"Role of subunit crosslinking in fibrin solubility","Scully M.F., Lane D.A., Dubiel M.K., Kakkar V.V.",0006291X,"Biochemical and Biophysical Research Communications",68, 4,0,0,0,0,0,0
1976,"Effect of dextran on clotting time: steric exclusion accelerates fibrin monomer polymerisation","Rampling M.W., Lane D.A., Kakkar V.V.",00493848,"Thrombosis Research",9, 4,3,0,0,0,0,3
1976,"A method for characterising serum fibrinogen and fibrin degradation products","Lane D.A., Scully M.F., Kakkar V.V.",00493848,"Thrombosis Research",9, 2,0,0,0,0,0,0
1976,"A comparison of the sulphite and thrombin methods for measuring fibrinogen concentration of plasma from patients undergoing thrombolytic therapy","Lane D.A., Rampling M.W., Kakkar V.V.",00098981,"Clinica Chimica Acta",71, 1,0,0,0,0,0,0
1976,"Fibrinogen subunit degradation in vitro: studies on human fibrinogen heterogeneity","Scully M.F., Lane D.A., Thomas D.P., Kakkar V.V.",00493848,"Thrombosis Research",8, 4,0,0,0,0,0,0
1976,"Effect of steric exclusion by dextran on the conversion of fibrinogen into fibrin","Rampling M.W., Lane D.A., Kakkar V.V.",03005127,"Biochemical Society Transactions",4, 4,0,0,0,0,0,0
1975,"Characterisation of a soluble D dimer E complex in crosslinked fibrin digests","Gaffney P.J., Lane D.A., Kakkar V.V., Brasher M.",00493848,"Thrombosis Research",7, 1,7,0,1,1,1,9
1975,"Soluble high molecular weight E fragments in the plasmin induced degradation products of cross linked human fibrin","Gaffney P.J., Lane D.A., Brasher M.",03010538,"Clinical Science and Molecular Medicine",49, 2,3,0,0,0,0,3
1975,"Proceedings: Amine inhibition of fibrin cross-linking.","Dubiel M.K., Scully M.F., Lane D.A., Kakkar V.V.",03405338,"Thrombosis et diathesis haemorrhagica",34, 2,0,0,0,0,0,0
1975,"Proceedings: Characterisation of a soluble high molecular weight e fragment released by plasmin from cross-linked fibrin.","Lane D.A., Brasher M., Kakkar V.V., Gaffney P.J.",03405338,"Thrombosis et diathesis haemorrhagica",34, 1,0,0,0,0,0,0
1974,"The dispersion of solutes during blood flow through a straight tube","Lane D.A., Sirs J.A.",00223751,"Journal of Physiology",241, 3,0,0,0,0,0,0
1974,"INDICATOR DILUTION MEASUREMENT OF MEAN TRANSIT TIME AND FLOW IN A STRAIGHT TUBE.","LANE D.A., SIRS J.A.",00223735,"Journal of Physics E: Scientific Instruments",7, 1,0,0,0,0,0,0
1973,"The influence of diffusion on indicator-dilution measurements of blood flow.","Bate H., Lane D.A., Sirs J.A.",00223751,"Journal of Physiology",230, 1,0,0,0,0,0,0
